首页 | 本学科首页   官方微博 | 高级检索  
     检索      


In vivo pharmacokinetics of pyribenzoxim in rats
Authors:Kwang‐Hyeon Liu  Joon‐Kwan Moon  Ha‐Jung Sung  Seung‐Hun Kang  Suk‐Jin Koo  Hye‐Suk Lee  Jeong‐Han Kim
Abstract:Pyribenzoxim, benzophenone O‐2,6‐bis(4,6‐dimethoxypyrimidin‐2‐yloxy)benzoyl]oxime, is a new post‐emergence herbicide providing broad‐spectrum weed control in rice fields. 14C]Pyribenzoxim was used to study the pharmacokinetics of the compound after oral administration of a dose of 1000 mg kg?1 to male Sprague–Dawley rats. The material balance ranged from 97.3 to 99.7% of the administered dose and urinary and fecal recovery accounted for 97.1%, with the majority of radioactivity recovered in feces (88.6%) by 168 h after treatment. Elimination as volatile products or as carbon dioxide was negligible. The following values were obtained for the compound in the blood: AUC0–168h, 28400 µg equiv h g?1; Tmax, 12 h; Cmax, 372 µg equiv g?1; half‐life, 53 h. Radioactivity in tissue decreased from 96.1% of applied radiocarbon at 6 h to 0.4% at 168 h and the highest concentration of radioactivity among the tissues was observed in liver while the lowest residues were found in brain. The elimination half‐lives of radioactivity from tissues was in the range of 7 to 77 h and Tmax values of 12, 24 and 12 h were observed for blood, liver and kidney, respectively. Except for that in the digestive tract, the tissue‐to‐blood ratio (TBR) was highest in the liver. © 2001 Society of Chemical Industry
Keywords:pyribenzoxim  pharmacokinetics  elimination  rat  herbicide
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号